Nephropathy in Type 2 Diabetes Mellitus

1 medicine

Diabetic nephropathy is kidney damage caused by long-term high blood sugar in type 2 diabetes and a leading cause of chronic kidney disease worldwide, managed with blood sugar and blood pressure control plus medicines such as irbesartan.

Avapro

Irbesartan

150/300mg

Avapro is a heart blood pressure medication containing Irbesartan, available as 150/300mg tablets.

from $1.06 / tablet View

Key facts

  • Diabetic nephropathy is kidney damage that develops when persistently high blood sugar injures the tiny filtering vessels inside the kidneys.
  • It is a serious complication of type 2 diabetes and one of the leading causes of chronic kidney disease worldwide.
  • Treatment centers on tight glucose control, blood pressure management, and medicines such as irbesartan that block the renin-angiotensin system to cut protein loss and slow kidney damage.
  • Any sudden drop in urine output, significant leg swelling, or marked breathlessness needs prompt assessment.

What is happening in the kidneys

Diabetic nephropathy develops when persistently high blood sugar injures the tiny filtering vessels inside the kidneys. Over years, this damage lets protein leak into the urine and gradually reduces how well the kidneys filter waste. It is a serious complication of type 2 diabetes and one of the most common causes of end-stage kidney disease, and rates have risen alongside the global increase in type 2 diabetes over the past two decades.

How nephropathy in type 2 diabetes is managed

The central aim is slowing the decline in kidney function. Tight glucose control and blood pressure management are the cornerstones. Medicines that block the renin-angiotensin system, including irbesartan and related agents, reduce protein leakage into the urine (proteinuria) and slow structural damage to the kidneys. These agents also manage the raised blood pressure that frequently accompanies kidney disease; related treatments are listed under heart and blood pressure. Dietary changes, particularly limiting sodium and protein intake, support these effects. Regular monitoring of kidney function tests (eGFR, creatinine) and urine protein helps guide treatment adjustments over time.

When to see a doctor

Any sudden drop in urine output, significant swelling of the legs, or marked shortness of breath should be assessed promptly.

This page is educational and does not replace advice from a doctor or pharmacist who knows your health history.